Published 3 days ago • loading... • Updated 2 days ago
How to Manage Symptoms of Heart Failure
The guidance urges ongoing outpatient management and notes a nasal spray diuretic that can help patients avoid immediate intravenous therapy.
On Monday, new guidance introduced ENBUMYST, a prescription nasal spray diuretic, as an at-home option for adults managing heart failure symptoms before escalating to intravenous therapy.
Americans face a growing health challenge, with 1 in 4 adults at risk of heart failure, according to the Heart Failure Society. Diuretics, sometimes referred to as "water pills," help manage swelling associated with the condition.
ENBUMYST is administered as a short-term nasal spray to help the body remove excess fluid, with treatment aimed at transitioning patients to oral diuretic therapy when appropriate. Monitoring for side effects like dehydration and kidney function changes is required.
Ongoing outpatient care is important when managing heart failure, requiring patients to adhere to their healthcare team's treatment plan and communicate if symptoms worsen or treatment appears ineffective.
Approximately 6.7 million adults currently live with heart failure, projected to reach 8.7 million by 2030, with healthcare costs rising from $40 billion in 2020 to approximately $142 billion by 2050.